Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiology | 13 | 2023 | 2113 | 2.260 |
Why?
|
Radiology, Interventional | 10 | 2023 | 476 | 1.080 |
Why?
|
Students, Medical | 4 | 2020 | 1936 | 1.070 |
Why?
|
Quality-Adjusted Life Years | 7 | 2022 | 1722 | 0.890 |
Why?
|
Internship and Residency | 7 | 2023 | 5882 | 0.850 |
Why?
|
Biliary Tract Surgical Procedures | 1 | 2022 | 45 | 0.810 |
Why?
|
Calculi | 1 | 2022 | 48 | 0.800 |
Why?
|
Sea Anemones | 1 | 2021 | 15 | 0.790 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2022 | 793 | 0.780 |
Why?
|
Biliary Tract | 1 | 2022 | 135 | 0.770 |
Why?
|
Physicians | 5 | 2023 | 4591 | 0.770 |
Why?
|
Tuberculosis | 3 | 2023 | 2017 | 0.750 |
Why?
|
Economic Development | 1 | 2021 | 70 | 0.730 |
Why?
|
Carotid Body Tumor | 1 | 2021 | 34 | 0.730 |
Why?
|
International Agencies | 1 | 2021 | 243 | 0.730 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2022 | 133 | 0.730 |
Why?
|
Cholelithiasis | 1 | 2022 | 407 | 0.720 |
Why?
|
Blood Group Antigens | 1 | 2022 | 184 | 0.710 |
Why?
|
Paraganglioma | 1 | 2022 | 142 | 0.700 |
Why?
|
Embolization, Therapeutic | 4 | 2023 | 1418 | 0.680 |
Why?
|
Coronary Aneurysm | 1 | 2022 | 232 | 0.660 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2021 | 194 | 0.660 |
Why?
|
Cholestasis | 1 | 2022 | 378 | 0.650 |
Why?
|
Pelvic Pain | 1 | 2021 | 298 | 0.650 |
Why?
|
Scientific Misconduct | 1 | 2020 | 74 | 0.650 |
Why?
|
Prostatic Hyperplasia | 1 | 2022 | 521 | 0.620 |
Why?
|
Developing Countries | 2 | 2021 | 2885 | 0.620 |
Why?
|
Life Expectancy | 2 | 2022 | 1243 | 0.610 |
Why?
|
Education, Medical | 2 | 2020 | 1725 | 0.610 |
Why?
|
Awards and Prizes | 1 | 2022 | 360 | 0.590 |
Why?
|
Publications | 1 | 2019 | 194 | 0.560 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2022 | 536 | 0.560 |
Why?
|
Authorship | 1 | 2020 | 284 | 0.550 |
Why?
|
Fatty Liver | 1 | 2022 | 790 | 0.520 |
Why?
|
Organizational Culture | 1 | 2019 | 509 | 0.510 |
Why?
|
Physicians, Women | 1 | 2021 | 509 | 0.480 |
Why?
|
Respiratory Tract Infections | 1 | 2022 | 1010 | 0.470 |
Why?
|
Neurosurgery | 1 | 2020 | 679 | 0.450 |
Why?
|
Humans | 72 | 2024 | 761596 | 0.430 |
Why?
|
Schools, Medical | 1 | 2019 | 879 | 0.420 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3086 | 0.410 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3206 | 0.410 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 2 | 2023 | 141 | 0.380 |
Why?
|
HIV Infections | 3 | 2023 | 17354 | 0.380 |
Why?
|
Hypertension, Pulmonary | 1 | 2022 | 1578 | 0.380 |
Why?
|
Medicine | 1 | 2019 | 942 | 0.370 |
Why?
|
Point-of-Care Systems | 1 | 2019 | 1213 | 0.360 |
Why?
|
Laparoscopy | 1 | 2022 | 2036 | 0.360 |
Why?
|
Arteriovenous Malformations | 2 | 2023 | 396 | 0.350 |
Why?
|
Education, Medical, Undergraduate | 1 | 2019 | 1070 | 0.340 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2022 | 2297 | 0.340 |
Why?
|
Liver Neoplasms | 2 | 2023 | 4317 | 0.340 |
Why?
|
Bayes Theorem | 3 | 2022 | 2330 | 0.340 |
Why?
|
Radiography | 5 | 2021 | 6965 | 0.330 |
Why?
|
Alcohol Drinking | 1 | 2022 | 4028 | 0.330 |
Why?
|
Artificial Intelligence | 2 | 2022 | 2578 | 0.320 |
Why?
|
Biomedical Research | 2 | 2024 | 3429 | 0.300 |
Why?
|
Vascular Malformations | 2 | 2024 | 468 | 0.290 |
Why?
|
Curriculum | 4 | 2020 | 3743 | 0.260 |
Why?
|
Sclerotherapy | 2 | 2024 | 182 | 0.250 |
Why?
|
Risk Factors | 9 | 2023 | 74213 | 0.250 |
Why?
|
Health Services Accessibility | 1 | 2022 | 5440 | 0.240 |
Why?
|
Ovarian Neoplasms | 1 | 2021 | 4878 | 0.240 |
Why?
|
Neoplasms | 3 | 2024 | 22173 | 0.220 |
Why?
|
Nephrostomy, Percutaneous | 1 | 2023 | 76 | 0.210 |
Why?
|
Pyridinolcarbamate | 1 | 2022 | 4 | 0.210 |
Why?
|
Epistaxis | 1 | 2023 | 112 | 0.210 |
Why?
|
Publishing | 2 | 2020 | 833 | 0.200 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6938 | 0.200 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2023 | 128 | 0.190 |
Why?
|
Poliovirus Vaccines | 1 | 2021 | 13 | 0.190 |
Why?
|
Sex Characteristics | 2 | 2022 | 2639 | 0.190 |
Why?
|
Digestive System Abnormalities | 1 | 2021 | 49 | 0.190 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2021 | 52 | 0.190 |
Why?
|
Gross Domestic Product | 1 | 2021 | 78 | 0.190 |
Why?
|
Child Mortality | 1 | 2023 | 205 | 0.190 |
Why?
|
Financing, Organized | 1 | 2022 | 204 | 0.190 |
Why?
|
Measles Vaccine | 1 | 2021 | 80 | 0.180 |
Why?
|
Cause of Death | 2 | 2021 | 3683 | 0.180 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2022 | 296 | 0.180 |
Why?
|
Shock | 1 | 2023 | 314 | 0.180 |
Why?
|
Vascular Neoplasms | 1 | 2022 | 166 | 0.180 |
Why?
|
Arteriovenous Fistula | 1 | 2023 | 319 | 0.180 |
Why?
|
Industry | 1 | 2022 | 364 | 0.180 |
Why?
|
Child | 9 | 2024 | 80158 | 0.180 |
Why?
|
Restless Legs Syndrome | 1 | 2023 | 233 | 0.170 |
Why?
|
Geography | 1 | 2022 | 656 | 0.170 |
Why?
|
Seroepidemiologic Studies | 1 | 2021 | 397 | 0.170 |
Why?
|
Career Mobility | 1 | 2022 | 259 | 0.170 |
Why?
|
Prostatic Neoplasms | 1 | 2022 | 11122 | 0.170 |
Why?
|
Female | 15 | 2023 | 392705 | 0.170 |
Why?
|
Pulmonary Circulation | 1 | 2022 | 737 | 0.170 |
Why?
|
Child, Preschool | 4 | 2022 | 42232 | 0.170 |
Why?
|
Cough | 1 | 2023 | 594 | 0.160 |
Why?
|
Government Programs | 1 | 2021 | 279 | 0.160 |
Why?
|
Kidney Calculi | 1 | 2023 | 463 | 0.160 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2023 | 369 | 0.160 |
Why?
|
Radiology Information Systems | 1 | 2023 | 529 | 0.160 |
Why?
|
Adult | 10 | 2023 | 221210 | 0.160 |
Why?
|
Malpractice | 1 | 2023 | 556 | 0.160 |
Why?
|
Shoulder | 1 | 2020 | 300 | 0.150 |
Why?
|
Pulmonary Veins | 1 | 2023 | 743 | 0.150 |
Why?
|
Financing, Government | 1 | 2021 | 472 | 0.150 |
Why?
|
South Africa | 1 | 2023 | 1843 | 0.150 |
Why?
|
Research Personnel | 1 | 2022 | 588 | 0.150 |
Why?
|
Male | 11 | 2023 | 360846 | 0.150 |
Why?
|
United States | 6 | 2023 | 72340 | 0.140 |
Why?
|
Fluoroscopy | 1 | 2021 | 947 | 0.140 |
Why?
|
Cryosurgery | 1 | 2022 | 474 | 0.140 |
Why?
|
Hemangioma | 1 | 2022 | 727 | 0.140 |
Why?
|
Morbidity | 1 | 2022 | 1752 | 0.140 |
Why?
|
Intestinal Diseases | 1 | 2021 | 504 | 0.140 |
Why?
|
Blood Loss, Surgical | 1 | 2021 | 638 | 0.140 |
Why?
|
Drainage | 1 | 2022 | 1157 | 0.140 |
Why?
|
Education, Medical, Graduate | 4 | 2023 | 2373 | 0.140 |
Why?
|
Education, Distance | 1 | 2020 | 261 | 0.130 |
Why?
|
Organizational Innovation | 1 | 2019 | 537 | 0.130 |
Why?
|
Cysts | 1 | 2021 | 681 | 0.130 |
Why?
|
Abdomen | 1 | 2022 | 1128 | 0.130 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2022 | 832 | 0.130 |
Why?
|
Aneurysm, Ruptured | 1 | 2021 | 464 | 0.130 |
Why?
|
Adipose Tissue, Brown | 1 | 2022 | 764 | 0.130 |
Why?
|
Public Opinion | 1 | 2019 | 484 | 0.130 |
Why?
|
Pandemics | 4 | 2022 | 8656 | 0.130 |
Why?
|
International Cooperation | 1 | 2021 | 1422 | 0.120 |
Why?
|
Mentors | 1 | 2020 | 661 | 0.120 |
Why?
|
Pulmonary Artery | 1 | 2023 | 1927 | 0.120 |
Why?
|
Prevalence | 2 | 2022 | 15733 | 0.120 |
Why?
|
Motivation | 2 | 2023 | 2006 | 0.120 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2022 | 934 | 0.120 |
Why?
|
Forecasting | 2 | 2022 | 2928 | 0.120 |
Why?
|
Burnout, Professional | 1 | 2023 | 704 | 0.110 |
Why?
|
Workload | 1 | 2019 | 844 | 0.110 |
Why?
|
Health Personnel | 2 | 2022 | 3335 | 0.110 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2021 | 1033 | 0.110 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2022 | 2009 | 0.110 |
Why?
|
Aged | 5 | 2022 | 169310 | 0.100 |
Why?
|
Prostate-Specific Antigen | 1 | 2022 | 2469 | 0.100 |
Why?
|
Career Choice | 1 | 2019 | 756 | 0.100 |
Why?
|
Treatment Outcome | 7 | 2024 | 64685 | 0.100 |
Why?
|
Preoperative Care | 1 | 2021 | 2242 | 0.100 |
Why?
|
Cost of Illness | 1 | 2021 | 1937 | 0.100 |
Why?
|
Mycobacterium tuberculosis | 1 | 2022 | 1914 | 0.100 |
Why?
|
Intracranial Aneurysm | 1 | 2021 | 1285 | 0.090 |
Why?
|
Middle Aged | 5 | 2022 | 220921 | 0.090 |
Why?
|
Particulate Matter | 1 | 2022 | 2605 | 0.090 |
Why?
|
Sensitivity and Specificity | 2 | 2022 | 14665 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2902 | 0.090 |
Why?
|
Coronary Angiography | 1 | 2022 | 4471 | 0.090 |
Why?
|
Stroke | 2 | 2022 | 9758 | 0.090 |
Why?
|
Hospitals | 1 | 2023 | 3883 | 0.080 |
Why?
|
Adipose Tissue | 1 | 2022 | 3313 | 0.080 |
Why?
|
Adolescent | 3 | 2022 | 88326 | 0.080 |
Why?
|
Students | 1 | 2019 | 1741 | 0.080 |
Why?
|
Catheter Ablation | 1 | 2023 | 2751 | 0.080 |
Why?
|
Retrospective Studies | 6 | 2024 | 80647 | 0.080 |
Why?
|
Brain Ischemia | 1 | 2022 | 3049 | 0.080 |
Why?
|
Health Expenditures | 1 | 2021 | 2366 | 0.080 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5337 | 0.080 |
Why?
|
Societies, Medical | 1 | 2020 | 3905 | 0.080 |
Why?
|
Infant, Newborn | 3 | 2023 | 26202 | 0.080 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7828 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3201 | 0.070 |
Why?
|
Quality of Health Care | 1 | 2022 | 4331 | 0.070 |
Why?
|
Aged, 80 and over | 2 | 2022 | 58984 | 0.070 |
Why?
|
Endovascular Procedures | 1 | 2021 | 2183 | 0.070 |
Why?
|
Epilepsy | 1 | 2022 | 3290 | 0.070 |
Why?
|
Primary Health Care | 1 | 2023 | 4687 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2023 | 4251 | 0.070 |
Why?
|
Ultrasonography | 1 | 2019 | 5971 | 0.070 |
Why?
|
Infant | 3 | 2023 | 36193 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3358 | 0.060 |
Why?
|
Smoking | 1 | 2022 | 9053 | 0.060 |
Why?
|
Young Adult | 2 | 2022 | 59260 | 0.060 |
Why?
|
Clinical Competence | 1 | 2021 | 4793 | 0.060 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2023 | 4575 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 26129 | 0.060 |
Why?
|
Quality of Life | 2 | 2023 | 13367 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9280 | 0.060 |
Why?
|
Sclerosing Solutions | 1 | 2024 | 79 | 0.060 |
Why?
|
Lung | 1 | 2022 | 10002 | 0.060 |
Why?
|
Incidence | 1 | 2021 | 21355 | 0.050 |
Why?
|
Pregnancy | 2 | 2021 | 29890 | 0.050 |
Why?
|
Polytetrafluoroethylene | 1 | 2023 | 245 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2022 | 7879 | 0.050 |
Why?
|
Tremor | 1 | 2023 | 191 | 0.050 |
Why?
|
Collateral Circulation | 1 | 2022 | 294 | 0.050 |
Why?
|
Perfusion Imaging | 1 | 2022 | 196 | 0.050 |
Why?
|
Risk Assessment | 1 | 2022 | 23996 | 0.050 |
Why?
|
Angioplasty | 1 | 2023 | 355 | 0.050 |
Why?
|
Rifampin | 1 | 2022 | 339 | 0.040 |
Why?
|
Manganese | 1 | 2023 | 393 | 0.040 |
Why?
|
Basal Ganglia | 1 | 2023 | 554 | 0.040 |
Why?
|
Veins | 1 | 2024 | 768 | 0.040 |
Why?
|
Pathology, Molecular | 1 | 2022 | 328 | 0.040 |
Why?
|
Time Factors | 1 | 2021 | 39969 | 0.040 |
Why?
|
Ileum | 1 | 2021 | 557 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20568 | 0.040 |
Why?
|
Diagnostic Imaging | 2 | 2024 | 3530 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2022 | 463 | 0.040 |
Why?
|
Infant Mortality | 1 | 2023 | 759 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13381 | 0.040 |
Why?
|
Kidney | 2 | 2023 | 7048 | 0.040 |
Why?
|
Uncertainty | 1 | 2022 | 754 | 0.040 |
Why?
|
India | 1 | 2023 | 2348 | 0.030 |
Why?
|
Doxorubicin | 1 | 2023 | 2224 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2023 | 1116 | 0.030 |
Why?
|
Water | 1 | 2022 | 1411 | 0.030 |
Why?
|
Cerebral Angiography | 1 | 2021 | 1281 | 0.030 |
Why?
|
Prospective Studies | 3 | 2023 | 54423 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1935 | 0.030 |
Why?
|
Hemorrhage | 1 | 2023 | 3424 | 0.020 |
Why?
|
Animals | 1 | 2021 | 168475 | 0.020 |
Why?
|
Databases, Factual | 1 | 2023 | 7968 | 0.020 |
Why?
|
Genomics | 1 | 2024 | 5821 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10212 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 22176 | 0.020 |
Why?
|
Algorithms | 1 | 2024 | 14033 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2023 | 39106 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 36426 | 0.010 |
Why?
|
Brain | 1 | 2022 | 27121 | 0.010 |
Why?
|
Concepts
(221)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_